Mr. Damien McCallion:

We are managing that very carefully at the moment. We are not incurring costs over and above what we are testing. In some cases, we have had to stock up on tests. In the public hospital system we have tried to purchase ahead so that we are not caught with some of the problems we had at the start and ensure we have a stockpile that brings us forward in terms of reagents, test kits and so on. In some cases we are advance purchasing so that we do not get caught with supply chain difficulties further down the line.